Digital transformation is reshaping the private markets, making burdensome compliance tasks manageable and streamlining business processes, says Workiva investments industry principal Arthy Kumar.
More creative financing and deal structures will spur healthcare investment and exit activity beyond the current focus on trophy assets and add-ons, say Ropes & Gray’s Neill Jakobe and Carolyn Vardi.
The convergence of tech and biology is creating a compelling investment environment for the sector, say Brett Zbar and Mark Stevenson at General Atlantic.
Buoyed by growth trends, buyouts in the lower mid-market offer significant opportunities for value creation, says Vesey Street Capital Partners’ Adam Feinstein.
Providing inclusive and equal opportunities is closely tied to wider social and sustainability issues, all of which hinge on changing behaviours, says Ardian’s head of sustainability, Candice Brenet.
Even amid a wider dealflow drought, Germany’s mid-market is thriving. This comes as a result of relatively low PE penetration, fragmented industries and a new generation of ambitious managers.
Pharma services is creating cross-border opportunities, but GPs should be aware of regulatory and structural issues at play in different jurisdictions, say McDermott Will & Emery’s Kristian Werling and Ellie West.
EY’s Bridget Walsh explains how GPs are refining their value-creation strategies and repositioning themselves towards emerging opportunities in a dislocated market.
Good data management can streamline operations, improve risk management and help firms differentiate themselves from their peers, says Sam Metland, executive vice-president and head of private equity product at Citco UK.
Private funds must rely on fund administrators now more than ever as the outsourcing landscape becomes increasingly fraught, write RSM US’s Christa Clark and Louis Crasto.